U.S. Markets open in 2 hrs 48 mins

Merck gets EU panel nod for first ever Ebola vaccine

Oct 18 (Reuters) - A panel of the European drugs regulator on Friday recommended approving Merck & Co's vaccine for the deadly Ebola virus.

The European Medicines Agency said https://bit.ly/2MrRw4c its human medicines committee (CHMP) has recommended granting a conditional marketing authorisation in the European Union for the vaccine, Ervebo, for individuals aged 18 years and older. (Reporting by Pushkala Aripaka in Bengaluru Editing by Saumyadeb Chakrabarty)